Drug interactions for women with diabetes and obesity during pregnancy

C. Newman; F. P. Dunne; A. M. Egan

doi:10.1016/B978-0-323-89904-8.00012-3

Drug interactions for women with diabetes and obesity during pregnancy

C. Newman, F. P. Dunne, A. M. Egan

Research output: Chapter in Book or Conference Publication/Proceeding › Chapter › peer-review

1 Citation (Scopus)

Abstract

Diabetes is an extremely common complication of pregnancy and confers additional risks to both mother and foetus. Many therapeutic strategies, including pharmacological agents are emloyed to ensure strict glycaemic control and to optimise outcomes.

Original language	English
Title of host publication	Handbook of Obesity in Obstetrics and Gynecology
Publisher	Elsevier
Pages	307-316
Number of pages	10
ISBN (Electronic)	9780323899048
ISBN (Print)	9780323899123
DOIs	https://doi.org/10.1016/B978-0-323-89904-8.00012-3
Publication status	Published - 1 Jan 2023

Keywords

antiplatelet
foetus
hyperglycaemia
hypoglycaemia
oestrogen
Pregnancy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/B978-0-323-89904-8.00012-3

Cite this

@inbook{fece684a772f4569adb986a667b017d5,

title = "Drug interactions for women with diabetes and obesity during pregnancy",

abstract = "Diabetes is an extremely common complication of pregnancy and confers additional risks to both mother and foetus. Many therapeutic strategies, including pharmacological agents are emloyed to ensure strict glycaemic control and to optimise outcomes.",

keywords = "antiplatelet, foetus, hyperglycaemia, hypoglycaemia, oestrogen, Pregnancy",

author = "C. Newman and Dunne, {F. P.} and Egan, {A. M.}",

year = "2023",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-89904-8.00012-3",

language = "English",

isbn = "9780323899123",

pages = "307--316",

booktitle = "Handbook of Obesity in Obstetrics and Gynecology",

publisher = "Elsevier",

}

TY - CHAP

T1 - Drug interactions for women with diabetes and obesity during pregnancy

AU - Newman, C.

AU - Dunne, F. P.

AU - Egan, A. M.

PY - 2023/1/1

Y1 - 2023/1/1

N2 - Diabetes is an extremely common complication of pregnancy and confers additional risks to both mother and foetus. Many therapeutic strategies, including pharmacological agents are emloyed to ensure strict glycaemic control and to optimise outcomes.

AB - Diabetes is an extremely common complication of pregnancy and confers additional risks to both mother and foetus. Many therapeutic strategies, including pharmacological agents are emloyed to ensure strict glycaemic control and to optimise outcomes.

KW - antiplatelet

KW - foetus

KW - hyperglycaemia

KW - hypoglycaemia

KW - oestrogen

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=85156199608&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-89904-8.00012-3

DO - 10.1016/B978-0-323-89904-8.00012-3

M3 - Chapter

AN - SCOPUS:85156199608

SN - 9780323899123

SP - 307

EP - 316

BT - Handbook of Obesity in Obstetrics and Gynecology

PB - Elsevier

ER -

Drug interactions for women with diabetes and obesity during pregnancy

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this